The process of drug discovery and the Yin/Yang of small-molecule/biotech option

Last but not least, biotech drugs can be 'copied' as well, since we now have biosimilar drugs, although the pathway to develop copies of biotech drugs remains steeper compared to that leading to the equivalents of small-molecule drugs.